Artificial Heart-Lung Machine Market Size, Share, Growth, and Industry Analysis, By Type (Single Roller Pump and Double Roller Pump), By Downstream Industry (Cardiac Surgery, Lung Transplantation Operations, Acute Respiratory Failure Treatment and Others) and Regional Forecast to 2033

• 

  Request a Free sample to learn more about this report

ARTIFICIAL HEART-LUNG MACHINE MARKET REPORT OVERVIEW

The Artificial Heart-Lung Machine Market stood at USD 0.3 Billion in 2024 and is set to expand to USD 0.31 Billion in 2025, eventually reaching USD 0.45 Billion by 2033, driven by a CAGR of 4.47%.

Artificial-heart-lung machines are very important apparatus during an open-heart surgery that assist in performing the functions of the heart and lungs. The procedure of these machines is to withdraw blood from the venous system of a patient and then route it through an oxygenator that removes the carbon dioxide introduces the oxygen into the blood and then processes it into a circuit. This reperfusion blood may then be returned to the arterial tree and thus, for example, oxygenate and nourish the heart brain kidneys and liver, although they are deprived of the body's own circulating blood while the routine physical activity is performed and the heart is at rest. These perfusion techniques then allow surgeons to perform valve operations, congenital defects and coronary bypasses with accuracy in an area that is not flooded with blood during the process of the operation.

This is the heart-lung machine that is run by the medical perfusionist, that is, the medical officer responsible for maintaining the physiological status of the patient under vigilance. This machine was first utilized in 1953, first offered by American medic John H. Gibbon, Junior in operating an atrial septal defect. This paradigm shift turned out to be of vital importance and set up the foundation for further development in the technology of CPB, which is nowadays an integral part of many surgical operations, including pediatric and neonatal surgery. Heart-lung machines have made the skills to perform complicated operations better and have increased patients' success rates after undergoing cardio surgeries.

COVID-19 IMPACT

Pandemic undermine the market due to the reduction in non-essential surgeries

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The artificial heart-lung market has been significantly affected by unanticipated occurrences such as the pandemic. There has been increased pressure to allocate resources and develop healthcare infrastructure that would address the pandemic and this is the reason why there has been delay in other surgeries that are non-urgent such as many cardiac surgeries. This led to a decrease in the demand for artificial heart-lung machines during the early days of the outbreak. Hospitals prioritized COVID-19 patients and, consequently, performed fewer elective and non-emergency surgeries, thereby limiting the demand and market development of these crucial devices.

LATEST TRENDS

Increasingly incorporating artificial intelligence algorithms to drive the market

The proper application of artificial intelligence (AI) to artificial heart-lung machines is reinventing patient diagnosis and treatment as well as contributing to harmonizing monitoring abilities and decision-making processes. Using the data gathered in real-time from the machine and the patient AI algorithms can assist medical personnel in making a much better decision on the course to take during the operation. These algorithms can detect possible complications, recommend variations of the specific equipment settings and even control blood flow and the levels of oxygen in the body. Also, AI is useful in handling individual patient needs that may require personalization in handling hence enhancing the safety and efficiency of treatment. This advanced integration not only improves the accuracy and stability of artificial heart-lung machines but also helps perfusionists and surgeons to provide better patient care at a lesser risk to patients.

Request a Free sample to learn more about this report

ARTIFICIAL HEART-LUNG MACHINE MARKET SEGMENTATION

By Type

Based on type the global market can be categorized into Single Roller Pump and Double Roller Pump.

• Single Roller Pump: In single roller pump-type heart-lung machines, blood is propelled down the circuit by a single rotating roller. This design is simpler and the devices are generally less expensive compared with double roller pump models. Single roller pumps are indicated for smaller patients, such as children and infants since they require lower blood flow rates. They may, however, be more prone to haemolysis as the shear stress on blood exerted by a single roller would be higher.

• Double Roller Pump: In double-roller pump artificial heart-lung machines, two rotating rollers pump blood through the circuit. This design provides better control over blood flow and can accommodate a wider range of patient sizes, from infant to adult. The double roller pumps are usually applied in programs requiring more stable and continuous blood flow that can help avoid hemolysis and other complications. They are generally of a higher price compared with the single-roller pump models available but with more functionalities and versatility.

By Downstream Industry

Based on downstream industry the global market can be categorized into Cardiac Surgery, Lung Transplantation Operations, Acute Respiratory Failure Treatment and Others.

• Cardio surgery: This is best represented by coronary artery bypass grafting and heart valve repairs. These are huge artificial heart-lung machines in operation during cardiac surgery to maintain proper circulation and oxygenation when blood flow is stopped. Rising incidents of CVDs increased the need for such operations, which in turn boosted the market growth. Improvements in technology in the context of enhancing the efficiency and safety of the machines help further enhance their adoption and, hence, their contribution to the market.

• Lung Transplantation Operations: During lung transplantation, artificial heart-lung machines supply the required amount of oxygenation and blood flow during such complicated surgical operations. Their usage is growing due to the rising incidence of chronic respiratory diseases and lung transplants. Improving surgical techniques and post-operative care improved the outcomes, further increasing its demand. The segment is probably to grow further when more patients require transplants due to deteriorating air quality and changing lifestyles.

• Acute Respiratory Failure Treatment: The human heart-lung machines that are artificial are crucial in treating acute respiratory failure by oxygenating blood and removing carbon dioxide when the lungs fail. This life-saving support is vital in critical care. The critical care given to patients using such life-saving devices is of invaluable importance. Rising respiratory diseases such as pneumonia and COPD raise demand for such machines. Improving technology that increases their efficiency has fueled exponential growth in this segment with the changing healthcare systems.

• Others: The "Others" segment of artificial heart-lung machines also comprises research, training and other miscellaneous medical procedures that prove the versatility of the applications. They also find an application in non-traditional settings such as academic institutions and specialized centres. With the advancement in medical innovation, this segment may see growing demand in the future. The research being carried out with continuous technological development might further enhance its applicability, thus propelling the growth of the market.

DRIVING FACTORS

Rising prevalence of cardiovascular diseases boosts the market

The increase in the number of patients suffering from cardiovascular diseases, including coronary artery diseases and heart failure, is proving to be a major factor fueling the global artificial heart-lung machine market growth. These machines have proven to be a valuable tool to surgeons as they enhance the accuracy and success of difficult and delicate surgeries such as coronary artery bypass grafts or heart valve replacements. Artificial heart-lung machines help in continuing blood circulation and oxygenation as well, while the heart is stopped, thus providing the desired bloodless surgical situation, a cardinal for these delicate operations. The increasing prevalence and incidence rates of cardiovascular diseases in people across the world ensure that the need for sophisticated operations increases in tandem, thereby driving the overall heart lung machine market. Advancements related to the technology of these devices provided additional boosts to their capabilities and effectiveness, which has made them indispensable in today’s practice of cardiac surgery and the advancement of the quality of patient care.

Growing geriatric population is rising at a fast pace for market expansion

The geriatric population is rising at a fast pace so artificial heart-lung machines are in tremendous demand. More prone to heart attack or coronary artery disease as well as heart failure are older people, who need complicated surgical procedures. Most of these are major surgery procedures. Therefore, the ageing population is a vital niche market that drives the demand for these machines. Cardiac surgical procedures require the assistance of artificial heart-lung machines because they help maintain an uninterrupted blood flow and oxygen supply during the operations. This population ageing is expected to fuel significant market expansion in the future years. Furthermore, improvements in using heart-lung machines are further strengthening their utility and safety, these machines are more important in managing aged cardiovascular diseases, in addition to pushing the growth of this market.

RESTRAINING FACTORS

High cost of equipment and their maintenance act as a barrier to the market

High tech advanced and highly capable artificial heart-lung machines are very expensive to procure and maintain. This substantial expenditure constitutes a major issue, especially for healthcare organizations in poorer countries or regions with limited financial capabilities. The cost embraces not only the acquisition price but also other expenses, both direct and indirect, including maintenance and repair costs and operating costs which put most institutions off. Therefore, due to the high costs of these machines, there is a possibility that their use and access may be restricted in low-income regions of the world thereby limiting its market adoption in such regions. To solve this problem, further research aimed at finding efficient and affordable solutions and adequate aid is necessary in the attempt to promote the spread of those devices in various healthcare settings.

• Request a Free sample to learn more about this report

•  

ARTIFICIAL HEART-LUNG MACHINE MARKET REGIONAL INSIGHTS

North America dominates the market driven by the presence of well-established healthcare infrastructure

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

North America leads the global artificial heart-lung machine market share due to the presence of advanced and well-developed healthcare systems in the region. The combined use and development of heart-lung machines are well established within the region which is home to many prestigious medical facilities, advanced technologies and experienced professional medical teams. Advanced healthcare systems in most countries of North America ensure that these complex devices are availed and used depending on complicated heart and lung operations. Also, strong and continued commitment to medical innovation and research holds promising advancements in heart-lung technology, which further strengthens the regional market position. Technological advancements, coupled with the existence of a strong infrastructure within the healthcare industry in North America, as well as an increased incidence of heart diseases in the region, ensure continuous dominance of North America in the market.

KEY INDUSTRY PLAYERS

Key industry players are expanding their market presence through distribution, partnerships and local manufacturing

The key market players are actively working on widening company growth in emerging market segments due to rising demand for artificial heart-lung machines. This expansion implies the creation of effective distribution channels, partnerships with other companies or organizations and manufacturing subsidiaries. To be more precise, the relevance of carrying out specific operations is higher for localizing organizations because they can better meet the requirements of these areas, for instance, by offering relatively cheap solutions or effectively solving logistical issues. A key opportunity is the continued expansion of healthcare spending coupled with growing rates of cardiovascular diseases within emerging economies. It also helps to maintain local presence which is essential for quick response and improved feedback on customer support and market-cutting measures. These strategic moves are important in regards to gaining a market share in emerging markets and concern with the overall industry development of artificial heart-lung machines.

List of Top Artificial Heart-Lung Machine Companies

• SynCardia (U.S.)
• Medtronic (U.S.)
• Jarvik Heart (U.S.)
• C. R. Bard (U.S.)
• Edwards (U.S.)
• Terumo (U.S.)
• Braile Biomedica (Brazil)
• Sorin Group (Italy)
• MAQUET (Germany)
• Tianjin Medical (China)

INDUSTRIAL DEVELOPMENT

February 2024: SynCardia Systems LLC reported the approval of its “Next Generation Total Artificial Heart” patent application from the United States Patent and Trademark Office (USPTO). This innovative design integrates the pumping mechanism within the artificial heart, eliminating external drive systems and moving closer to a fully implantable solution. CEO Patrick NJ Schnegelsberg highlighted the potential impact on over 3,000 advanced heart failure patients.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.